Academic Journal
COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death.
| Τίτλος: | COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death. |
|---|---|
| Συγγραφείς: | Alene KA; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia kefyalew.alene@curtin.edu.au.; School of Population Health, Curtin University, Perth, Western Australia, Australia.; Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, Ethiopia., Gelaw YA; Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, Ethiopia.; School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia., Fetene DM; Burnet Institute, Melbourne, Victoria, Australia., Koye DN; Department of Medicine at Royal Melbourne Hospital and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Melaku YA; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Gesesew H; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.; School of Public Health, Mekelle University, Mekelle, Ethiopia., Birhanu MM; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.; St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia., Adane AA; Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, Ethiopia.; Telethon Kids Institute, The University of Western Australia, Nedlands, Western Australia, Australia., Muluneh MD; Western Sydney University, Penrith South, New South Wales, Australia.; Monitoring Evaluation and Research, Amref Health Africa in Ethiopia, Addis Ababa, Ethiopia., Dachew BA; School of Population Health, Curtin University, Perth, Western Australia, Australia.; Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, Ethiopia., Abrha S; University of Canberra, Canberra, Australian Capital Territory, Australia.; School of Pharmacy, Mekelle University, Mekelle, Ethiopia., Aregay A; Monash University, Clayton, Victoria, Australia.; School of Nursing, Mekelle University, Mekelle, Ethiopia., Ayele AA; School of Pharmacy, University of Gondar, Gondar, Ethiopia.; University of New England, Armidale, New South Wales, Australia., Bezabhe WM; University of Tasmania Faculty of Health, Hobart, Tasmania, Australia., Gebremariam KT; School of Public Health, Mekelle University, Mekelle, Ethiopia.; Queensland University of Technology, Brisbane, Queensland, Australia.; Lifelong Health, South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia., Gebremedhin T; University of Canberra, Canberra, Australian Capital Territory, Australia., Gebremedhin AT; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia.; School of Population Health, Curtin University, Perth, Western Australia, Australia., Gebremichael L; School of Pharmacy, Mekelle University, Mekelle, Ethiopia.; School of Pharmacy and Medical Sciences, Therapeutics Research Centre, University of South Australia, Adelaide, South Australia, Australia., Geleto AB; Haramaya University, Dire Dawa, Ethiopia.; Faculty of Health and Medicine, The University of Newcastle, Callaghan, New South Wales, Australia., Kassahun HT; Australian Rivers Institute, Griffith University, Nathan, Queensland, Australia., Kibret GD; College of Health Science, Debre Markos University, Debre Markos, Ethiopia.; University of Technology Sydney, Sydney, New South Wales, Australia., Leshargie CT; College of Health Science, Debre Markos University, Debre Markos, Ethiopia.; University of Technology Sydney, Sydney, New South Wales, Australia., Mekonnen A; Deakin University, Burwood, Victoria, Australia.; School of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia., Mirkuzie AH; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA., Mohammed H; Vaccinology and Immunology Research Trials Unit, Women's and Children's Hospital, Adelaide, South Australia, Australia.; Robinson Research Institute, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Tegegn HG; University of New England, Armidale, New South Wales, Australia.; Clinical Pharmacy Department, School of Pharmacy, University of Gondar, Gondar, Ethiopia., Tesema AG; School of Public Health, Mekelle University, Mekelle, Ethiopia.; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia., Tesfay FH; School of Public Health, Mekelle University, Mekelle, Ethiopia.; Deakin University, Geelong, Institute for Health Transformation, Melbourne, Victoria, Australia., Wubishet BL; Faculty of Health and Medicine, The University of Newcastle, Callaghan, New South Wales, Australia., Kinfu Y; University of Canberra, Canberra, Australian Capital Territory, Australia.; College of Medicine, Qatar University, Doha, Qatar. |
| Πηγή: | BMJ open [BMJ Open] 2021 Feb 18; Vol. 11 (2), pp. e044606. Date of Electronic Publication: 2021 Feb 18. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [London] : BMJ Publishing Group Ltd, 2011- |
| Ιατρικοί όροι (MeSH): | Geography, Medical*, COVID-19/*epidemiology, COVID-19/mortality ; Ethiopia/epidemiology ; Female ; Humans ; Male ; Pandemics ; Risk Factors |
| Περίληψη: | Background: COVID-19 has caused a global public health crisis affecting most countries, including Ethiopia, in various ways. This study maps the vulnerability to infection, case severity and likelihood of death from COVID-19 in Ethiopia. Methods: Thirty-eight potential indicators of vulnerability to COVID-19 infection, case severity and likelihood of death, identified based on a literature review and the availability of nationally representative data at a low geographic scale, were assembled from multiple sources for geospatial analysis. Geospatial analysis techniques were applied to produce maps showing the vulnerability to infection, case severity and likelihood of death in Ethiopia at a spatial resolution of 1 km×1 km. Results: This study showed that vulnerability to COVID-19 infection is likely to be high across most parts of Ethiopia, particularly in the Somali, Afar, Amhara, Oromia and Tigray regions. The number of severe cases of COVID-19 infection requiring hospitalisation and intensive care unit admission is likely to be high across Amhara, most parts of Oromia and some parts of the Southern Nations, Nationalities and Peoples' Region. The risk of COVID-19-related death is high in the country's border regions, where public health preparedness for responding to COVID-19 is limited. Conclusion: This study revealed geographical differences in vulnerability to infection, case severity and likelihood of death from COVID-19 in Ethiopia. The study offers maps that can guide the targeted interventions necessary to contain the spread of COVID-19 in Ethiopia. (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Competing Interests: | Competing interests: None declared. |
| References: | Sci Total Environ. 2020 Aug 10;729:138997. (PMID: 32353724) Sci Data. 2017 Jan 31;4:170004. (PMID: 28140397) JAMA. 2020 May 19;323(19):1908-1909. (PMID: 32275299) Environ Res. 2020 Jul;186:109625. (PMID: 32668557) Lancet Infect Dis. 2020 May;20(5):523-524. (PMID: 32145766) Int Rev Educ. 2020;66(4):575-602. (PMID: 32836371) Int J Biol Sci. 2020 Mar 15;16(10):1745-1752. (PMID: 32226294) Lancet. 2020 Mar 14;395(10227):871-877. (PMID: 32087820) Nature. 2019 Feb;566(7745):467-474. (PMID: 30814711) Public Health Rev. 2015 Dec 09;36:14. (PMID: 29450042) BMJ. 2020 Apr 7;369:m1395. (PMID: 32265194) JAMA. 2020 Apr 21;323(15):1499-1500. (PMID: 32159735) J Infect. 2020 Aug;81(2):e16-e25. (PMID: 32335169) Afr Health Sci. 2019 Sep;19(3):2580-2590. (PMID: 32127831) Travel Med Infect Dis. 2020 Mar - Apr;34:101626. (PMID: 32184132) Lancet Glob Health. 2020 Apr;8(4):e480. (PMID: 32109372) Lancet. 2020 Mar 21;395(10228):931-934. (PMID: 32164834) PLoS One. 2020 Nov 2;15(11):e0241327. (PMID: 33137155) N Engl J Med. 2020 Jun 18;382(25):e102. (PMID: 32356626) Eur Respir J. 2020 Jul 9;56(1):. (PMID: 32457198) Nature. 2018 Jan 18;553(7688):333-336. (PMID: 29320477) Sci Total Environ. 2020 Aug 10;729:138705. (PMID: 32361432) BMJ Glob Health. 2020 Sep;5(9):. (PMID: 32948617) Alcohol Alcohol. 2020 Jun 25;55(4):344-346. (PMID: 32400858) BMJ Open. 2020 Nov 19;10(11):e040402. (PMID: 33444201) Acta Biomed. 2020 Mar 19;91(1):157-160. (PMID: 32191675) Rand Health Q. 2017 Jun 19;6(3):5. (PMID: 28845357) Cell Mol Immunol. 2020 May;17(5):555-557. (PMID: 32235915) JAMA. 2020 May 19;323(19):1915-1923. (PMID: 32275295) Science. 2020 Apr 24;368(6489):395-400. (PMID: 32144116) |
| Contributed Indexing: | Keywords: epidemiology; public health |
| Entry Date(s): | Date Created: 20210219 Date Completed: 20210225 Latest Revision: 20231110 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC7896372 |
| DOI: | 10.1136/bmjopen-2020-044606 |
| PMID: | 33602713 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!